These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30830481)

  • 1. Buspirone Hydrochloride Loaded In Situ Nanovesicular Gel as an Anxiolytic Nasal Drug Delivery System: In Vitro and Animal Studies.
    Abdelnabi DM; Abdallah MH; Elghamry HA
    AAPS PharmSciTech; 2019 Mar; 20(3):134. PubMed ID: 30830481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
    Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
    Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ gels of Metoclopramide Hydrochloride for intranasal delivery: in vitro evaluation and in vivo pharmacokinetic study in rabbits.
    Mahajan HS; Gattani S
    Drug Deliv; 2010 Jan; 17(1):19-27. PubMed ID: 19958151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbopol-incorporated thermoreversible gel for intranasal drug delivery.
    Balakrishnan P; Park EK; Song CK; Ko HJ; Hahn TW; Song KW; Cho HJ
    Molecules; 2015 Mar; 20(3):4124-35. PubMed ID: 25749681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
    Khan S; Patil K; Yeole P; Gaikwad R
    J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats.
    Bshara H; Osman R; Mansour S; El-Shamy Ael-H
    Carbohydr Polym; 2014 Jan; 99():297-305. PubMed ID: 24274510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin.
    Mura P; Mennini N; Nativi C; Richichi B
    Eur J Pharm Biopharm; 2018 Jan; 122():54-61. PubMed ID: 29032194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal mucoadhesive buspirone formulation: in vitro characterization and nasal clearance studies.
    Khan SA; Patil KS; Yeole PG
    Pharmazie; 2008 May; 63(5):348-51. PubMed ID: 18557417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of Tamsulosin Hydrochloride-Loaded Mucoadhesive In Situ Gelling Polymeric Formulation for Nasal Delivery in Geriatrics.
    Rana SJ; Zafar S; Shahzad A; Basit M; Mudassir J; Akhlaq M; Chohan TA; Arshad MS
    AAPS PharmSciTech; 2023 Nov; 24(8):242. PubMed ID: 38017208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies.
    Shelke S; Shahi S; Jalalpure S; Dhamecha D
    J Liposome Res; 2016 Dec; 26(4):313-23. PubMed ID: 26758957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
    Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
    Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Blatta orientalis (Q) nasal gel formulation in milk aspiration induced eosinophilia.
    Nimgulkar CC; Patil SD; Chauk DS
    Pharm Dev Technol; 2009; 14(4):435-41. PubMed ID: 19552565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and Evaluation of Thermoreversible In Situ Nasal Gels Containing Mometasone Furoate for Allergic Rhinitis.
    Altuntaş E; Yener G
    AAPS PharmSciTech; 2017 Oct; 18(7):2673-2682. PubMed ID: 28281209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain delivery of buspirone hydrochloride chitosan nanoparticles for the treatment of general anxiety disorder.
    Bari NK; Fazil M; Hassan MQ; Haider MR; Gaba B; Narang JK; Baboota S; Ali J
    Int J Biol Macromol; 2015 Nov; 81():49-59. PubMed ID: 26210037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal In Situ Gel of Apixaban-Loaded Nanoethosomes: Preparation, Optimization, and In Vivo Evaluation.
    El-Shenawy AA; Mahmoud RA; Mahmoud EA; Mohamed MS
    AAPS PharmSciTech; 2021 May; 22(4):147. PubMed ID: 33948767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced bioavailability of buspirone hydrochloride via cup and core buccal tablets: formulation and in vitro/in vivo evaluation.
    Kassem MA; Elmeshad AN; Fares AR
    Int J Pharm; 2014 Mar; 463(1):68-80. PubMed ID: 24412520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: Preparation, characterization and in vivo evaluation.
    Youssef NAHA; Kassem AA; Farid RM; Ismail FA; El-Massik MAE; Boraie NA
    Int J Pharm; 2018 Sep; 548(1):609-624. PubMed ID: 30033394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride.
    Cho HJ; Balakrishnan P; Park EK; Song KW; Hong SS; Jang TY; Kim KS; Chung SJ; Shim CK; Kim DD
    J Pharm Sci; 2011 Feb; 100(2):681-91. PubMed ID: 20803575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies.
    Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO
    Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Permeation of buspirone hydrochloride across animal buccal mucosa and its mechanism].
    Du Q; Ping QN; Liu G
    Yao Xue Xue Bao; 2001 Aug; 36(8):621-4. PubMed ID: 12579943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.